Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Inventory (2016 - 2020)

Plus Therapeutics (PSTV) has disclosed Inventory for 11 consecutive years, with $107000.0 as the latest value for Q3 2020.

  • On a quarterly basis, Inventory changed 0.0% to $107000.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $107000.0, a 0.0% change, with the full-year FY2019 number at $107000.0, changed 0.0% from a year prior.
  • Inventory was $107000.0 for Q3 2020 at Plus Therapeutics, roughly flat from $107000.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $4.5 million in Q2 2016 to a low of $107000.0 in Q4 2018.
  • A 5-year average of $2.3 million and a median of $3.0 million in 2018 define the central range for Inventory.
  • Peak YoY movement for Inventory: increased 11.15% in 2016, then tumbled 96.64% in 2018.
  • Plus Therapeutics' Inventory stood at $3.7 million in 2016, then fell by 14.55% to $3.2 million in 2017, then crashed by 96.64% to $107000.0 in 2018, then changed by 0.0% to $107000.0 in 2019, then changed by 0.0% to $107000.0 in 2020.
  • Per Business Quant, the three most recent readings for PSTV's Inventory are $107000.0 (Q3 2020), $107000.0 (Q2 2020), and $107000.0 (Q1 2020).